Drug Discovery
REIMAGINED.
Our mission is to provide the world‘s most advanced service platform to unlock chemical matter and help to bring the most innovative medicines to patients. Since the inception of the company, we have successfully pioneered our “structural data first” approach to unlock untapped potential of difficult targets.
CrystalsFirst provides cutting-edge solutions to unlock chemical matter for protein targets. Our discovery platform and flexible business model have a proven track record of successful campaign with global pharma and biotech companies.
what partners say about us
"CrystalsFirst is a recognized expert in crystallographic fragment screening and co-structure determination to unlock chemical matter. The company has always focused on meeting our expectations, taking the time to understand the project and its complexities.
We enjoyed collaborating with the CrystalsFirst team and recommend CrystalsFirst’s expertise and services to other companies.”
CrystalsFirst’s platform significantly improved the crystallographic quality and unlocked the potential for a novel inhibition mechanism of our target of interest.
Their team is distinguished by flexible problem skills and pro-active communication.
We absolutely recommend CrystalsFirst’s expertise and services to other companies!
"CrystalsFirst is a recognized structural biology expert providing services for
structure-based drug discovery. Their team was very accommodating, meeting very tight timelines of the project, and communicating proactively throughout the project. CrystalsFirst's technology and distinguished problem-solving skills helped to determine co-structures where
other companies had significant challenges. We enjoyed collaborating with the CrystalsFirst team and recommend CrystalsFirst's expertise and
services to other companies."
Previous
Next
Our Alliances
